National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
METOCLOPRAMIDE INJECTION , USP
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
NDC00703-4502-04 | 0A423 | A | 5 | 2 | 4 | ZZ | ||
NDC00703-4502-04 | 0Y512 | A | 5 | 2 | 4 | ZZ | ||
NDC60977-0451-01 | 1QN08 | A | 3 | 2 | 4 | ZZ | ||
REGLAN | 1QN08 | A | 5 | 1 | 4 | ZZ |
CAGE Information
Code | Company |
---|---|
0A423 | CARDINAL HEALTH 100 INC DBA BINDLEY |
0Y512 | SICOR PHARMACEUTICALS SALES INC |
1QN08 | BAXTER PHARMACEUTICAL PRODUCTS INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS METOCLOPRAMIDE EQUIVALENT PER MILLILITER |
CSGS | ADMINISTRATION | INTRAMUSCULAR OR INTRAVENOUS |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
CQCT | PRIMARY CONTAINER TYPE | VIAL |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
AJCN | PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | METOCLOPRAMIDE INJECTION USP 5MG/ML 2ML VIAL 25S |
SUPP | SUPPLEMENTARY FEATURES | NOTE: F |